SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-074170
Filing Date
2018-03-08
Accepted
2018-03-08 07:09:10
Documents
48
Period of Report
2018-03-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d533714d8k.htm 8-K 17932
2 EX-99.1 d533714dex991.htm EX-99.1 80250
3 EX-99.2 d533714dex992.htm EX-99.2 40907
4 GRAPHIC g533714ex99_2s10g1.jpg GRAPHIC 246120
5 GRAPHIC g533714ex99_2s11g1.jpg GRAPHIC 347724
6 GRAPHIC g533714ex99_2s12g1.jpg GRAPHIC 288202
7 GRAPHIC g533714ex99_2s13g1.jpg GRAPHIC 420312
8 GRAPHIC g533714ex99_2s14g1.jpg GRAPHIC 121591
9 GRAPHIC g533714ex99_2s15g1.jpg GRAPHIC 186365
10 GRAPHIC g533714ex99_2s16g1.jpg GRAPHIC 261063
11 GRAPHIC g533714ex99_2s17g1.jpg GRAPHIC 292360
12 GRAPHIC g533714ex99_2s18g1.jpg GRAPHIC 211940
13 GRAPHIC g533714ex99_2s19g1.jpg GRAPHIC 147303
14 GRAPHIC g533714ex99_2s1g1.jpg GRAPHIC 350697
15 GRAPHIC g533714ex99_2s20g1.jpg GRAPHIC 223601
16 GRAPHIC g533714ex99_2s21g1.jpg GRAPHIC 186632
17 GRAPHIC g533714ex99_2s22g1.jpg GRAPHIC 189838
18 GRAPHIC g533714ex99_2s23g1.jpg GRAPHIC 257048
19 GRAPHIC g533714ex99_2s24g1.jpg GRAPHIC 328858
20 GRAPHIC g533714ex99_2s25g1.jpg GRAPHIC 180345
21 GRAPHIC g533714ex99_2s26g1.jpg GRAPHIC 163111
22 GRAPHIC g533714ex99_2s27g1.jpg GRAPHIC 203695
23 GRAPHIC g533714ex99_2s28g1.jpg GRAPHIC 251003
24 GRAPHIC g533714ex99_2s29g1.jpg GRAPHIC 260003
25 GRAPHIC g533714ex99_2s2g1.jpg GRAPHIC 265789
26 GRAPHIC g533714ex99_2s30g1.jpg GRAPHIC 192737
27 GRAPHIC g533714ex99_2s31g1.jpg GRAPHIC 285017
28 GRAPHIC g533714ex99_2s32g1.jpg GRAPHIC 386026
29 GRAPHIC g533714ex99_2s33g1.jpg GRAPHIC 265776
30 GRAPHIC g533714ex99_2s34g1.jpg GRAPHIC 199136
31 GRAPHIC g533714ex99_2s35g1.jpg GRAPHIC 118480
32 GRAPHIC g533714ex99_2s36g1.jpg GRAPHIC 315276
33 GRAPHIC g533714ex99_2s37g1.jpg GRAPHIC 274650
34 GRAPHIC g533714ex99_2s38g1.jpg GRAPHIC 237968
35 GRAPHIC g533714ex99_2s39g1.jpg GRAPHIC 245348
36 GRAPHIC g533714ex99_2s3g1.jpg GRAPHIC 196038
37 GRAPHIC g533714ex99_2s40g1.jpg GRAPHIC 241989
38 GRAPHIC g533714ex99_2s41g1.jpg GRAPHIC 94284
39 GRAPHIC g533714ex99_2s42g1.jpg GRAPHIC 366642
40 GRAPHIC g533714ex99_2s43g1.jpg GRAPHIC 321565
41 GRAPHIC g533714ex99_2s44g1.jpg GRAPHIC 287576
42 GRAPHIC g533714ex99_2s4g1.jpg GRAPHIC 424846
43 GRAPHIC g533714ex99_2s5g1.jpg GRAPHIC 280647
44 GRAPHIC g533714ex99_2s6g1.jpg GRAPHIC 218160
45 GRAPHIC g533714ex99_2s7g1.jpg GRAPHIC 165095
46 GRAPHIC g533714ex99_2s8g1.jpg GRAPHIC 277486
47 GRAPHIC g533714ex99_2s9g1.jpg GRAPHIC 257038
48 GRAPHIC g533714g0308051947659.jpg GRAPHIC 5859
  Complete submission text file 0001193125-18-074170.txt   15353149
Mailing Address 200 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 200 SIDNEY STREET CAMBRIDGE MA 02139 617 945 9626
Seres Therapeutics, Inc. (Filer) CIK: 0001609809 (see all company filings)

IRS No.: 274326290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37465 | Film No.: 18675005
SIC: 2834 Pharmaceutical Preparations